A Phase # Clinical Study Trial of Felbinac Trometamol Injection in China
Clinical trial NCT05297669 · COMPLETED
Trial details
- NCT number
- NCT05297669
- Sponsor
- Shijiazhuang Yiling Pharmaceutical Co. Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-23
- Primary completion
- 2022-01-19
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.